Recall of BLOOD GROUP REAGENT ANTI-S (UPPER CASE) FOR INDIRECT ANTIGLOBULIN TEST

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ORTHO-CLINICAL DIAGNOSTICS.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    45120
  • Event Risk Class
    II
  • Event Initiated Date
    2008-05-01
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Five lots of blood grouping reagent anti-s for indirect antiglobulin tests have been the subject of complaints of weakened reactivity or false negative reactions for positive controls.

Device

  • Model / Serial
    Model Catalog: 723030 (Lot serial: SS188D); Model Catalog: 723030 (Lot serial: SS188C); Model Catalog: 723030 (Lot serial: SS189A); Model Catalog: 723030 (Lot serial: SS189B); Model Catalog: 723030 (Lot serial: SS189C)
  • Product Description
    BLOOD GROUPING REAGENT ANTI-S
  • Manufacturer

Manufacturer